贛能股份(000899.SZ):董事長親屬買賣公司股票 屬個人行為
格隆匯2月5日丨贛能股份(000899.SZ)公佈,公司董事長陳萬波的親屬(兄弟)陳萬濱於2020年2月3日以均價4.19元/股買入4000股,成交金額為1.676萬元;於2020年2月4日以均價4.22元/股賣出1300股及以均價4.21元/股賣出2700股,成交金額合計為1.6853萬元。
經與陳萬濱確認,此次買賣公司股票行為是基於對公司的認可,屬於個人行為。其本人已將交易獲利金額交由公司所有;經公司核查,陳萬濱股票帳户的上述交易行為未發生在公司信息披露的敏感期內,亦不存在因知悉內幕信息而交易公司股票的情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.